Sign in
Not yet recruitingNo phase

Mechanical Insufflation-exsufflation and Hypertonic Saline in Nosocomial Bacterial Respiratory Tract Infection

Key facts

Who runs it
Hospital San Carlos, Madrid
Where
Spain7 sites in 1 countryChoose a country to see its sites
Trial code
Status
Not yet recruiting
People taking part
100 people, planned
Started
1 Jan 2026
Expected to end
30 Dec 2027
Type of study
Interventional, 3 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Mechanical insufflation-exsufflation
  • Standard of Care
  • Hypertonic saline with hyaluronic acid
Record updated
26 March 2025

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 9 criteriaShow less

Who can take part

  • Signed informed consent
  • Nosocomial pneumonia (vHAP or VAP) or nosocomial tracheobronchitis
  • Intubated with a cuffed endotracheal tube or tracheostomy cannula

Who cannot take part

  • Bronchospasm (patients on bronchodilators for previous bronchospasm may be included
  • Suspected unmonitored intracraneal hypertension
  • Ominous prognosis
  • Frank hemoptisis
  • Barotrauma (pneumothorax or pneumomediastinum)
  • Unstable thoracic cage

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Multicenter, randomized open label clinical trial to evaluate IEM and HS as concomitant therapy for respiratory tract infection in patients under artificial ventilation in the ICU.

Read full original descriptionShow less

Lung infection is a serious complication that may occur during hospital stay and may need artificial respiration or even develop during artificial ventilation for other causes.

Current specific treatment consists of intravenous antibiotics. The current study evaluated whether aspiration and drainage of infected sputum helps curing this severe complication and whether nebulized HS has additional benefits, like loosening of secretions, eradicating bacteria or reducing inflammation.

The 3 groups in the trial

  • Standard of CareExisting treatment, for comparison

    Standard of care: Systemic antibiotic therapy according to local protocol and at the discretion of the attending intensivist.

  • Mechanical insufflation-exsufflation with hypertonic saline/hyaluronic acid cominationTreatment being tested

    Systemic antibiotic therapy choice according to local protocol and at the discretion of the attending intensivist plus Mechanical insufflation-exsufflation (MI-E sessión tid during the first 48 hours, followed by MI-E if secretions are present or suspected; recommended settings +50 cmH2O/-50 cmH2O) with simultaneous nebulization of hypertonic saline (7%) with hyaluronic acid (0.1%).

    Treatment: Mechanical insufflation-exsufflation and Hypertonic saline with hyaluronic acid

  • Mechanical insufflation-exsufflationTreatment being tested

    Systemic antibiotic therapy choice according to local protocol and at the discretion of the attending intensivist plus Mechanical insufflation-exsufflation (MI-E sessión tid during the first 48 hours, followed by MI-E if secretions are present or suspected; recommended settings +50 cmH2O/-50 cmH2O)

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Aspiration of Bronchial Secretions With Mechanical Insufflation-Exsufflation and Hypertonic Saline in Bacterial Nosocomial Tracheobronchitis and Pneumonia in Intubated Patients.
Record updated
26 March 2025